Dergiler / Experimental Biomedical Research / 2022 / Cilt: 5 - Sayı: 2

Cancer screening in the COVID-19 pandemic; Development of early diagnostic strategies

Sayfa
147–153
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Results: For all of the screening strategies, smear / HPV, FOBT and mammography, mean of screening cases, positive cases and biopsies had significantly decreased (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Early diagnosis is very important in some cancers such as breast, cervical and colorectal.
📊
Temel Bulgular & Veri:However, the COVID-19 pandemic has severely disrupted cancer screening programmers in many countries.
💡
Sonuç & Katkı:Results: For all of the screening strategies, smear / HPV, FOBT and mammography, mean of screening cases, positive cases and biopsies had significantly decreased (p
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2017-2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: Early diagnosis is very important in some cancers such as breast, cervical and colorectal. However, the COVID-19 pandemic has severely disrupted cancer screening programmers in many countries. In this study, it is aimed to contribute to the literature on this subject by reviewing the status of local cancer screenings during the pandemic period. Methods: This retrospective study includes the 114.727 people in the risky group for cancer screening determined in Bolu, Turkey as two groups. During 2017-2019 years was determined as pre-pandemic group while the year of 2020 was the pandemic group. Data about patients’ results of smear / HPV (Human Papilloma Virus), fecal occult blood test (FOBT) and mammography had analyzed and compared with chi-square test. Results: For all of the screening strategies, smear / HPV, FOBT and mammography, mean of screening cases, positive cases and biopsies had significantly decreased (p

🔖

Bu Makaleye Atıf Yap

Ozsari, S. (2022). Cancer screening in the COVID-19 pandemic; Development of early diagnostic strategies. Experimental Biomedical Research, Cilt: 5 - Sayı: 2, 147–153. https://ajindex.com/articles/512595

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Cancer Key Facts 12 September 2018. WHO. https://www.who.int/en/news- room/factsheets/detail/cancer. [2]TÜİK. Ölüm Nedeni İstatistikleri, 2016. http://tuik.gov.tr/PreTablo.do?alt_id=1083 [3]Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. [4]Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Kanser Dairesi Başkanlığı. Kanser Taramaları. https://hsgm.saglik.gov.tr/tr/kanser- taramalari [5]Waterhouse DM, Harvey RD, Hurley P, et al. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings from an American Society of Clinical Oncology Survey. JCO Oncol Pract. 2020;16(7):417-21. [6]de Jonge L, Worthington J, van Wifferen F, et al. COVID-19 and Cancer Global Modelling Consortium working group 2. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. Lancet Gastroenterol Hepatol. 2021;6(4):304-14. [7]J Lee. Thousands of cancer screening tests halted during pandemic restart in Alberta CBC Canada, Toronto, ON (May 27, 2020) https://www.cbc.ca/news/canada/calgary/al berta-cancer-screening-resumes-after- pandemic-suspension-1.5586513 [8]Degeling K, Baxter NN, Emery J, et al. An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic. Asia Pac J Clin Oncol. 2021;17(4):359-67. [9]Sharpless NE. COVID-19 and cancer. Science. 2020; 368(6497):1290. [10] Falco M. Common questions about the new coronavirus outbreak. American Cancer Society. 2020 Oct 12. URL: https://www.cancer.org/latest- news/common-questions-about-the-new- coronavirus-outbreak.html [11] Morrison DS. Recovering cancer screening in the pandemic: strategies and their impacts. Br J Cancer. 2021;124(9):1465-66. [12] Dinmohamed AG, Visser O, Verhoeven RHA, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21(6):750-51. [13] Kaufman HW, Chen Z, Niles J, Fesko Y. Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA Netw Open. 2020;3(8):e2017267. [14] Sud A, Torr B, Jones ME, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020;21(8):1035-44. [1